MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2016 International Congress

    Loss of FBXO7 (PARK15) leads to disturbances in proteasomal function and models parkinsonism-like and pyramidal symptoms in mice

    S. Vingill, D. Brockelt, N. Schwedhelm-Domeyer, L. Tatenhorst, S. Goebbels, P. Lingor, K.A. Nave, J. Stegmueller (Goettingen, Germany)

    Objective: To model Parkinsonian-pyramidal syndrome (PARK15) in mice and investigate the impact of loss of F-box only protein 7 (FBXO7) in neurons on proteasomal activity.…
  • 2016 International Congress

    Initial clinical description of progressive supranuclear palsy in the Luxembourg Parkinson’s study

    P. Kolber, G. Hipp, M. Kerschenmeyer, K. Roomp, S.K. Mosch, L. Longhino, A. Schweicher, M. Faltz, V.P. Satagopam, N. Goncharenko, M. Gantenbein, M. Vaillant, F. Betsou, A. Chioti, R. Schneider, R. Krüger (Esch-sur-Alzette, Luxembourg)

    Objective: To characterize the clinical features and prevalence of patients with progressive supranuclear palsy (PSP) in the recently implemented longitudinal Parkinson's cohort (HELP-PD). Background: PSP…
  • 2016 International Congress

    Comparative analysis of freezing of gait in distinct parkinsonism types by diffusion tensor imagining and cognitive profiles

    H. Onder, E.S. Topcuoglu, A.C. Has, K.K. Oguz, B. Elibol (Ankara, Turkey)

    Objective: To demonstrate possible disturbances in pedinculopontine nucleus (PPN) and its connections in freezing of gait (FOG) by DTI in conjunction with the cognitive profile.…
  • 2016 International Congress

    Sleep deprivation (SD) amongst carers of patients with Parkinson’s disease (PD)

    D. Kulatunga, H. Avery, A.K. Chatterjee, A. Plowman, J. Caffrey, S. Pradhan (Reading, United Kingdom)

    Objective: To identify nocturnal symptoms in patients which lead to sleep deprivation in carers of PD patients. Background: SD affects the health status of the…
  • 2016 International Congress

    Hypothalamic alpha-synuclein pathology and its relation to non-motor symptoms and disease progression in Parkinson’s disease

    E. De Pablo-Fernandez, R. Courtney, J.L. Holton, T.W. Warner (London, United Kingdom)

    Objective: To assess alpha-synuclein pathology and tyrosine hydroxylase (TH) immunoreactivity as a dopaminergic marker in three hypothalamic nuclei with potential clinical implications (paraventricular, supraoptic and…
  • 2016 International Congress

    Chronic levodopa treatment accelerates the disorders of circadian rhythm in 6-OHDA induced Parkinson’s disease model

    S. Li, Y. Wang, W. Liu, D. Lv, C. Liu (Suzhou, People's Republic of China)

    Objective: We aimed to study the effect of levodopa on circadian rhythms in 6-OHDA lesioned rats, and to clarify whether the disturbance of the circadian…
  • 2016 International Congress

    Idiopathic Parkinson’s disease presenting with dysphagia 15 years before PD diagnosis

    T. Munteanu, C. Goggins, D. Costigan, J. Molloy, T. O'Dwyer, T. Lynch (Dublin, Ireland)

    Objective: To describe an atypical presentation of Idiopathic Parkinson's disease. Background: Dysphagia is a commonly reported “non-motor” feature of Idiopathic Parkinson's disease (IPD), which usually…
  • 2016 International Congress

    Anxiolytic-like activity of the adenosine A2A receptor antagonist, istradefylline (KW-6002) in rodent models of anxiety

    K. Yamada, M. Kobayashi, J. Kase, A. Mori, P. Jenner, T. Kanda (Shizuoka, Japan)

    Objective: The aim of this study was to assess the anxiolytic effects of istradefylline (KW-6002), an adenosine A2A receptor antagonist, in naive and anxiety-prone animals…
  • 2016 International Congress

    Measurement of night time sleep using an accelerometry based system

    M. Horne, S. McGregor, G. Hamilton, D. O'Driscoll, R. Blaze, P. Churchward (Parkville, Australia)

    Objective: To establish whether accelerometry using the Parkinson Kinetigraph (PKG, Global Kinetics) can distinguish between normal and abnormal nocturnal sleep in Parkinson's disease (PD). Background:…
  • 2016 International Congress

    Exploring association of GBA variants with pre-diagnostic features of PD in the PREDICT-PD cohort: A nested case-control study

    L. R'Bibo, N.E. Mencacci, A. Schrag, J.P. Bestwick, L. Peress, J. Masters, G. Giovannoni, A.J. Lees, J. Hardy, N.W. Wood, A.J. Noyce (London, United Kingdom)

    Objective: To investigate the association of GBA variants with pre-diagnostic features of Parkinson's disease (PD) within the PREDICT-PD cohort. Background: Subtle motor and non-motor symptoms…
  • « Previous Page
  • 1
  • …
  • 104
  • 105
  • 106
  • 107
  • 108
  • …
  • 207
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley